Overview
VTVT market data
Price History
VTVT price chart
Valuation & Profitability
- P/E (TTM)
- 56.27 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.20 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.30 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $14.00 – $44.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $126.7 · P/B 2.59 · P/S 3.44.
Company News
Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For FridayBenzinga · Jul 17, 2026, 12:00 PM
BlackRock To Rally Around 25%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga · Jul 16, 2026, 11:57 AM
BTIG Maintains Buy on vTv Therapeutics, Raises Price Target to $57Benzinga · Jul 16, 2026, 9:46 AM
vTv Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.Benzinga · May 14, 2026, 4:35 PM
8-K filing — vTv Therapeutics Inc. (VTVT)SEC EDGAR · May 13, 2026, 9:20 PM
vTv Therapeutics Q1 EPS $1.65 Beats $(0.10) Estimate, Sales $36.839M Beat $20.000M EstimateBenzinga · May 13, 2026, 8:53 PM